Roxana Mehran, MD, FACC

General Statement of Disclosure:

CONSULTING FEES/HONORARIA: Abbott Laboratories(SIGNIFICANT), Boston Scientific(MODEST), Siemens(MODEST), Sanofi Aventis(SIGNIFICANT), Medtelligence (Janssen)(MODEST), Roivant Sciences(MODEST), Idorsia Pharmaceuticals Ltd (NONE), Bristol-Myers Squibb Company (SIGNIFICANT), The Medicines Company(MODEST), Abiomed(MODEST), Janssen Scientific Affairs(MODEST), PHILIPS/Spectranetics/Volcano(SIGNIFICANT), Regeneron Pharmaceuticals(NONE) RESEARCH/RESEARCH GRANTS: Bayer Healthcare Pharmaceuticals(SIGNIFICANT), Beth Israel Deaconess Medical Center(SIGNIFICANT), AstraZeneca Pharmaceuticals(SIGNIFICANT), CSL Behring (SIGNIFICANT), DSI(SIGNIFICANT), Medtronic(SIGNIFICANT), OrbusNeich(SIGNIFICANT), Novartis Corporation(SIGNIFICANT), Abbott Laboratories(SIGNIFICANT), Bristol-Myers Squibb Company (SIGNIFICANT) OTHER FINANCIAL BENEFIT: WebMD(MODEST), Elixir Medical(MODEST), Claret Medical(MODEST)

View Full Disclosure